Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.

Ubhi KK, Shaibah H, Newman TA, Shepherd D, Mudher A.

Invert Neurosci. 2007 Sep;7(3):165-71. Epub 2007 Jul 18.

PMID:
17636367
2.

Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.

Cowan CM, Chee F, Shepherd D, Mudher A.

Biochem Soc Trans. 2010 Apr;38(2):564-70. doi: 10.1042/BST0380564. Review.

PMID:
20298222
3.

Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.

Hannan SB, Dräger NM, Rasse TM, Voigt A, Jahn TR.

J Neurochem. 2016 Apr;137(1):12-25. doi: 10.1111/jnc.13532. Epub 2016 Feb 11. Review.

4.

Tauopathies and tau oligomers.

Takashima A.

J Alzheimers Dis. 2013;37(3):565-8. doi: 10.3233/JAD-130653. Review.

PMID:
23948895
5.

Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.

Zilka N, Korenova M, Novak M.

Acta Neuropathol. 2009 Jul;118(1):71-86. doi: 10.1007/s00401-009-0499-y. Epub 2009 Feb 24. Review.

PMID:
19238406
6.

Modulation of tau pathology in tau transgenic models.

Brion JP, Ando K, Heraud C, Leroy K.

Biochem Soc Trans. 2010 Aug;38(4):996-1000. doi: 10.1042/BST0380996. Review.

PMID:
20658992
7.

Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.

Lewis J, Dickson DW.

Acta Neuropathol. 2016 Jan;131(1):27-48. doi: 10.1007/s00401-015-1507-z. Epub 2015 Nov 17. Review.

PMID:
26576562
8.

Phosphorylation differentiates tau-dependent neuronal toxicity and dysfunction.

Papanikolopoulou K, Kosmidis S, Grammenoudi S, Skoulakis EM.

Biochem Soc Trans. 2010 Aug;38(4):981-7. doi: 10.1042/BST0380981. Review.

PMID:
20658989
9.

The power and richness of modelling tauopathies in Drosophila.

Papanikolopoulou K, Skoulakis EM.

Mol Neurobiol. 2011 Aug;44(1):122-33. doi: 10.1007/s12035-011-8193-1. Epub 2011 Jun 17. Review.

PMID:
21681411
10.

Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

Alavi Naini SM, Soussi-Yanicostas N.

Oxid Med Cell Longev. 2015;2015:151979. doi: 10.1155/2015/151979. Epub 2015 Oct 20. Review.

11.

Tau neurotoxicity without the lesions: a fly challenges a tangled web.

de Silva R, Farrer M.

Trends Neurosci. 2002 Jul;25(7):327-9. Review.

PMID:
12079751
12.

Are tangles as toxic as they look?

Spires-Jones TL, Kopeikina KJ, Koffie RM, de Calignon A, Hyman BT.

J Mol Neurosci. 2011 Nov;45(3):438-44. doi: 10.1007/s12031-011-9566-7. Epub 2011 Jun 3. Review. Erratum in: J Mol Neurosci. 2011 Nov 45(3):742.

13.

Roles of tau protein in health and disease.

Guo T, Noble W, Hanger DP.

Acta Neuropathol. 2017 May;133(5):665-704. doi: 10.1007/s00401-017-1707-9. Epub 2017 Apr 6. Review.

14.

From tau phosphorylation to tau aggregation: what about neuronal death?

Buée L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, Ahmed T, Fernandez-Gomez F, Caillierez R, Grosjean ME, Begard S, Barbot B, Demeyer D, Obriot H, Brion I, Buée-Scherrer V, Maurage CA, Balschun D, D'hooge R, Hamdane M, Blum D, Sergeant N.

Biochem Soc Trans. 2010 Aug;38(4):967-72. doi: 10.1042/BST0380967. Review.

PMID:
20658986
15.

Brief update on different roles of tau in neurodegeneration.

Ittner A, Ke YD, van Eersel J, Gladbach A, Götz J, Ittner LM.

IUBMB Life. 2011 Jul;63(7):495-502. doi: 10.1002/iub.467. Review.

16.

Tauopathies.

Hernández F, Avila J.

Cell Mol Life Sci. 2007 Sep;64(17):2219-33. Review.

PMID:
17604998
17.

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Ballatore C, Brunden KR, Huryn DM, Trojanowski JQ, Lee VM, Smith AB 3rd.

J Med Chem. 2012 Nov 8;55(21):8979-96. doi: 10.1021/jm301079z. Epub 2012 Sep 28. Review.

18.

Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

Badiola N, Suárez-Calvet M, Lleó A.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):727-40. Review.

PMID:
20942789
19.

Tau protein modifications and interactions: their role in function and dysfunction.

Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G.

Int J Mol Sci. 2014 Mar 18;15(3):4671-713. doi: 10.3390/ijms15034671. Review.

20.

[Neuropathology of tauopathy].

Yoshida M.

Brain Nerve. 2013 Dec;65(12):1445-58. Review. Japanese.

PMID:
24323931

Supplemental Content

Support Center